Gynaecological cancer: ADAMTS mutations predict sensitivity to chemotherapy in ovarian cancer.

doi:10.1038/nrclinonc.2015.122

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Gynaecological cancer: ADAMTS mutations predict sensitivity to chemotherapy in ovarian cancer.

Nature reviews. Clinical oncology - 1 Sept 2015

Errico Alessia

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ADAM Proteins
Share to Antineoplastic Agents
Share to Biomarkers, Tumor
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasms, Cystic, Mucinous, and Serous

Share to Ovarian Neoplasms

Source

Open in PubMed

Identifiers

PMID: 26122182
DOI: 10.1038/nrclinonc.2015.122

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Gynaecological cancer: ADAMTS mutations predict sensitivity to chemotherapy in ovarian cancer.PMID 26122182Read ↗

Association of Somatic Mutations of ADAMTS Genes With Chemotherapy Sensitivity and Survival in High-Grade Serous Ovarian Carcinoma.Semantic proximity Read ↗

The impact of molecular genetic diagnosis on the management of women with hCG-producing malignanciesSemantic proximity Read ↗

Hereditary gynecologic cancers: differential diagnosis, surveillance, management and surgical prophylaxis.Semantic proximity Read ↗

Management challenges in low-grade serous ovarian cancer with a BRCA mutation.Semantic proximity Read ↗

Ovarian cancer: identifying and managing familial and genetic risk-summary of new NICE guidance.Semantic proximity Read ↗

Hereditary gynaecological malignancies: advances in screening and treatment.Semantic proximity Read ↗

Developments in Genetics – a Better Management of Ovarian Cancer PatientsSemantic proximity Read ↗

Counselling and management of women with genetic predisposition to gynaecological cancers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.